Andon Health Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000Q84
CNY
40.84
2.96 (7.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,585.61
3,186.38
26,307.79
2,390.85
2,001.02
702.37
559.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,585.61
3,186.38
26,307.79
2,390.85
2,001.02
702.37
559.24
Raw Material Cost
809.16
1,238.23
5,448.28
952.23
940.37
566.74
444.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
69.42
15.23
6.73
17.16
9.60
10.49
8.66
Selling and Distribution Expenses
819.06
806.25
1,596.49
457.92
549.51
237.74
177.61
Other Expenses
18.01
24.85
24.02
3.18
4.91
4.91
4.86
Total Expenditure (Excl Depreciation)
1,877.72
2,308.17
7,291.73
1,459.12
1,548.62
864.05
679.77
Operating Profit (PBDIT) excl Other Income
707.9000000000001
878.1999999999999
19016.1
931.7
452.40000000000003
-161.70000000000002
-120.5
Other Income
792.94
746.70
254.48
68.37
317.77
14.71
220.91
Operating Profit (PBDIT)
1,535.48
1,603.83
18,894.17
1,084.66
825.83
-118.91
147.05
Interest
69.42
15.23
6.73
17.16
9.60
10.49
8.66
Exceptional Items
710.90
101.04
-485.31
30.49
-483.55
219.60
-88.44
Gross Profit (PBDT)
1,776.45
1,948.15
20,859.51
1,438.62
1,060.65
135.64
114.39
Depreciation
68.10
107.62
143.00
96.97
92.59
71.73
58.80
Profit Before Tax
2,108.86
1,582.02
18,259.12
1,001.01
240.08
18.47
-8.84
Tax
306.83
231.11
1,773.76
65.23
2.92
-8.68
-2.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,668.73
1,251.61
16,030.17
908.64
242.33
66.45
12.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,668.73
1,251.61
16,030.17
908.64
242.33
66.45
12.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
131.31
97.62
453.93
25.76
-5.50
-39.39
-15.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,800.04
1,349.23
16,484.09
934.40
236.83
27.06
-2.86
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
20,736.50
19,229.37
19,554.22
2,872.58
1,884.76
1,662.53
1,581.45
Earnings per share (EPS)
3.78
2.77
34.3
2.0
0.56
0.15
0.03
Diluted Earnings per share
3.78
2.77
34.3
2.0
0.56
0.15
0.03
Operating Profit Margin (Excl OI)
26.08%
23.52%
70.31%
38.45%
20.76%
-29.24%
-23.72%
Gross Profit Margin
84.19%
53.03%
69.95%
45.92%
16.63%
12.84%
8.93%
PAT Margin
64.54%
39.28%
60.93%
38.01%
12.11%
9.46%
2.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -18.86% vs -87.89% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 33.41% vs -91.82% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -13.37% vs -95.40% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 356.58% vs 126.87% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Andon Health Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,585.61
0
2,585.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,585.61
0
2,585.61
Raw Material Cost
809.16
0
809.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
69.42
0
69.42
Selling and Distribution Expenses
819.06
0
819.06
Other Expenses
18.01
0.00
18.01
Total Expenditure (Excl Depreciation)
1,877.72
0
1,877.72
Operating Profit (PBDIT) excl Other Income
707.89
0.00
707.89
Other Income
792.94
0
792.94
Operating Profit (PBDIT)
1,535.48
0
1,535.48
Interest
69.42
0
69.42
Exceptional Items
710.90
0
710.90
Gross Profit (PBDT)
1,776.45
0
1,776.45
Depreciation
68.10
0
68.10
Profit Before Tax
2,108.86
0
2,108.86
Tax
306.83
0
306.83
Provisions and contingencies
0
0
0.00
Profit After Tax
1,668.73
0
1,668.73
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,668.73
0
1,668.73
Share in Profit of Associates
0
0
0.00
Minority Interest
131.31
0
131.31
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,800.04
0
1,800.04
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
20,736.50
0
20,736.50
Earnings per share (EPS)
3.78
0
3.78
Diluted Earnings per share
3.78
0
3.78
Operating Profit Margin (Excl OI)
26.08%
0%
0.00
26.08%
Gross Profit Margin
84.19%
0%
0.00
84.19%
PAT Margin
64.54%
0%
0.00
64.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 258.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -18.86% vs -87.89% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 180.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 33.41% vs -91.82% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 74.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -13.37% vs -95.40% in Dec 2023

Annual - Interest
Interest 6.94 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 356.58% vs 126.87% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.08%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023